team headed by the principal investigator Prof. Dimitrios Karussis, M.D., Ph.D., Director of the Center for Multiple...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.
Multiple Sclerosis is part of Business Exchange, suggested by
Steve McCarthy.
This topic contains
967 news
and
242 blog
items.
Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from
like-minded professionals.
News
Please add new articles to this topic
for the drug, it said. Sativex, which is sprayed under the tongue as a treatment for spasticity in multiple sclerosis,...
Bartlet (Martin Sheen) attempted to come to grips with the death of a friend, the news of his multiple sclerosis...
in the increasingly diverse treatment algorithm. Your key questions answered * What are the key trends in the multiple...
a treatment for age-related macular degeneration and is conducting a 150-person trial of a drug to treat...
Extract not available.
at $96 billion last year. Israel���s largest company is looking for new engines of growth as its multiple sclerosis...
Extract not available.
a $6.2 billion deal. Israel's largest company is looking for new engines of growth as its multiple sclerosis drug...
emotional state. PBA outbursts result from a "short circuit" in the brain caused by another neurologic...
of GBR 500, a biological drug for the treatment of Crohn���s Disease and other inflammatory conditions like multiple...
the world's biggest generic drugmaker reduce its dependence on U.S. generics and on Copaxone, its leading multiple...
Extract not available.
with our scientific advisors to determine what further clinical studies might be warranted to support additional...
a $6.2 billion deal. Israel���s largest company is looking for new engines of growth as its multiple sclerosis drug...
health-care facilities with my team to determine potential space for patient care, but when we walked into the multiple...
Extract not available.
SNY) The drug, codenamed GBR500, is aimed at treating Crohn's disease and other inflammatory conditions such as...
fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients...
fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients...
this month's picks. Elan (NYSE: ELN There are risks here. Tysabri is Elan's popular treatment for multiple sclerosis...
on sales of products under the licence. The antibody, GBR500, used for the treatment of Crohn's disease, multiple...
six months post launch, market share of Novartis' Gilenya, the newest disease-modifying agent (DMA) for the treatment...
said to be leaving for personal reasons. Vieira's husband, news journalist Richard Cohen continues to struggle with...
charity partners, including the Princess Margaret Hospital Foundation and groups dedicated to fighting various...
Top Sources: Multiple Sclerosis
- St. Petersburg Times
- Reuters
- Chicago Tribune
- Mail Online UK
- MarketWatch
- BBC
- Boston Globe
- Philadelphia Inquirer
- BusinessWeek
- Seattle Times
account